Clinical Presentation of Left Atrial Cardiac Myxoma
Medicine 80:159-172, Pinede,L.,et al, 2001
Association Between Migraine and Endothelin Type A Receptor (ETA-231 A/G) Gene Polymorphism
Neurol 56 :1273-1277, Tzourio,C.,et al, 2001
A Hypothalamic Stroke Producing Recurrent Hemihyperhidrosis
Neurol 56:1394-1396, Smith,C.D., 2001
An Epidemic of Arsenic Neuropathy From a Spiked Curry
Neurol 56:1417-1418, Kishi,Y.,et al, 2001
Safety of Intra-Arterial Thrombolysis in the Postoperative Period
Stroke 32:1365-1369, Chalela,J.A.,et al, 2001
Barriers to Acute Stroke Therapy and Stroke Prevention in Mexican Americans
Stroke 32:1360-1364, Morgenstern,L.B.,et al, 2001
Malpractice Claims: Outcome Evidence to Guide Neurologic Education?
Neurol 56:1099-1100,991, Glick,T.H., 2001
Advances in the Genetics of Cerebrovascular Disease and Stroke
Neurol 56:997-1008, Hademenos,G.J.,et al, 2001
Cerebral Sinus Thrombosis with Tamoxifen
Neurol 56:1113-1114, Finelli,P.F. & Schauer,P.K., 2001
Monoataxia of Upper Extremity in Motor Cortical Infarction
Neurol 56:1418-1419, Noda,K.,et al, 2001
Endovascular Versus Surgical Treatment in Patients with Carotid Stenosis in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): A Randomised Trial
Lancet 357:1729-1737,1722, CAVATAS investigators, 2001
High-Density Lipoprotein Cholesterol and Ischemic Stroke in the Elderly
JAMA 285:2729-2735, Sacco,R.L.,et al, 2001
Clinical Carotid Endarterectomy Decision Making
Neurol 56:1009-1015,990, Johnston,D.C.C. & Goldstein,L.B., 2001
Why Are Stroke Patients Excluded from TPA Therapy?
Neurol 56:1015-1020, Barber,P.A.,et al, 2001
Cardiorespiratory Fitness and the Progression of Carotid Atherosclerosis in Middle-Aged Men
Ann Int Med 134:12-20, Lakka,T.A.,et al, 2001
Hyperdense Sylvian Fissure MCA "Dot" Sign
Stroke 32:84-88, Barber,P.A.,et al, 2001
Carotid Stenting for Radiation-Induced Stenoses
Stroke 32:118-121, Houdart,E.,et al, 2001
Delay in Presentation and Evaluation for Acute Stroke
Stroke 32:63-69, Lacy,C.R.,et al, 2001
Intake of Fish and Omega-3 Fatty Acids and Risk of Stroke in Women
JAMA 285:304-312, Iso,H.,et al, 2001
Primary Prevention of Ischemic Stroke
Stroke 32:280-299, Goldstein,L.B.,et al, 2001
Involuntary Movements After Anterior Cerebral Artery Territory Infarction
Stroke 32:258-261, Kim,J.S., 2001
Venous Thromboembolism After Acute Stroke
Stroke 32:262-267, Kelly,J.,et al, 2001
Circadian and Seasonal Occurrence of Subarachnoid and Intracerebral Hemorrhage
Neurol 56:190-193, Nyquist,P.A.,et al, 2001
Immediate Anticoagulation in Acute Focal Brain Ischemia Revisited
Stroke 32:577-578,579, Chamorro,A., 2001
Calcium Antagonists for Ischemic Stroke
Stroke 32:570-576, Horn,J. &Limburg,M., 2001
Assessment of Aspiration Risk in Stroke Patients with Quantification of Voluntary Cough
Neurol 56:502-506, Hammond,C.A.S.,et al, 2001
Suppression of Recurrent Transient Ischemic Attacks by a Statin Agent
Neurol 56:531-532, Alberts,M.J., 2001
Stroke Severity Determines Body Temperature in Acute Stroke
Stroke 32:413-417, Boysen,G. &Christensen,H., 2001
Detection of Helicobacter pylori in Human Carotid Atherosclerotic Plaques
Stroke 32:385-391, Ameriso,S.F.,et al, 2001
Combined Intraarterial/Intravenous Thrombolysis for Acute Ischemic Stroke
AJNR 22:352-358, Keris,V.,et al, 2001
Reversible Posterior Leukoencephalopathy During the Treatment of Acute Lymphoblastic Leukemia
Neurol 56:388-391, Shin,R.K.,et al, 2001
Frequency and Predictors of Stroke Death in 5,888 Participants in the Cardiovascular Health Study
Neurol 56:368-375, Longstreth,W.T.,et al, 2001
Systematic Review of Long Term Anticoagulation or Antiplatelet Treatment in Patients with Non-rheumatic Atrial Fibrillation
BMJ 322:321-326, Taylor,F.C.,et al, 2001
Prediction of Hemorrhagic Transformation Following Acute Stroke
Arch Neurol 58:587-593, Tong,D.C.,et al, 2001
Use of Specialized Coagulation Testing in the Evaluation of Patients with Acute Ischemic Stroke
Neurol 56:624-627, Bushnell,C.,et al, 2001
Spinal Cord Involvement in Primary Angiitis of the Central Nervous System: A Report of Two Cases
AJNR 22:577-582, Campi,A.,et al, 2001
Clinical Deterioration Following Improvement in the NINDS rt-PA Stroke Trial
Stroke 32:661-668, Grotta,J.C.,et al, 2001
Stroke as a Complication of Cardiac Catheterization: Risk Factors and Clinical Features
Neurol 56:975-977, Segal,A.Z.,et al, 2001
Cerebrovascular Manifestations in 321 Cases of Hereditary Hemorrhagic Telangiectasia
Stroke 32:877-882, Maher,C.O.,et al, 2001
Phenylpropanolamine and Hemorrhagic Stroke
NEJM 344:1094-1095, Ernst,M.E.,et al, 2001
Sustained Bilateral Hemodynamic Benefit of Contralateral Carotid Endarterectomy in Patients with Symptomatic Internal Carotid Artery Occlusion
Stroke 32:728-734, Rutgers,D.R.,et al, 2001
Acute and Long-Term Increase in Fracture Risk After Hospitalization for Stroke
Stroke 32:702 -706, Kanis,J.,et al, 2001
Warfarin Therapy for an Octogenarian who has Atrial Fibrillation
Ann Int Med 134:465-474, Gage,B.F.,et al, 2001
Spontaneous Dissection of the Carotid and Vertebral Arteries
NEJM 344:898-906, Schievink,W.I., 2001
Recurrent Brain Hemorrhage is More Frequent Than Ischemic Stroke After Intracranial Hemorrhage
Neurol 56:773-777, Bailey,R.D.,et al, 2001
Evolution of Apparent Diffusion Coefficient, Diffusion-weighted, and T2-weighted Signal Intensity of Acute Stroke
AJNR 22:637-644, Lansberg,M.G.,et al, 2001
Timing of Spontaneous Recanalization and Risk of Hemorrhagic Transformation in Acute Cardioembolic Stroke
Stroke 32:1079-1084, Molina,C.A.,et al, 2001
Intravenous tPA for Ischemic Stroke Team Performance Over Time, Safety, and Efficacy in a Single-Center, 2-Year Experience
Stroke 32:1074-1078, Koennecke,H.,et al, 2001
Viability Thresholds of Ischemic Penumbra of Hyperacute Stroke Defined by Perfusion-Weighted MRI and Apparent Diffusion Coefficient
Stroke 32:1140-1146, Rohl,L.,et al, 2001
Status Epilepticus After Stroke
Stroke 32:1169-1172, Velioglu,S.K.,et al, 2001